Last reviewed · How we verify

NCT03727308: MOC

Study of Clinic-based Versus Self-use of Medical Abortion Pills

Completed Last updated 5 September 2021
What this trial tests

trial testing Medical abortion pills sourced from pharmacies in Induced Abortion in 4,196 participants. Completed in 2 June 2021.

Timeline
30 May 2018
Primary endpoint
2 June 2021
2 June 2021

Quick facts

Lead sponsorIpas
StatusCompleted
Study typeOBSERVATIONAL
Enrollment4,196
Start date30 May 2018
Primary completion2 June 2021
Estimated completion2 June 2021
Sites2 locations across Cambodia, Ghana

Drugs / interventions tested

Conditions studied

Sponsor

Ipas — full company profile →

Who can join

15 and older, female only, with Induced Abortion or First Trimester Abortion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the study is to determine whether important clinical outcomes differ among women who access a combined medical abortion regimen from a pharmacy when compared with those who access it from a facility.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Self-administered versus provider-administered medical abortion.
    Gambir K, Kim C, Necastro KA, Ganatra B, et al · · 2020 · cited 23× · PMID 32150279 · DOI 10.1002/14651858.cd013181.pub2
  2. Medical methods for first trimester abortion.
    Zhang J, Zhou K, Shan D, Luo X. · · 2022 · cited 19× · PMID 35608608 · DOI 10.1002/14651858.cd002855.pub5
  3. A prospective, comparative study of clinical outcomes following clinic-based versus self-use of medical abortion.
    Kapp N, Mao B, Menzel J, Eckersberger E, et al · · 2023 · cited 12× · PMID 36894309 · DOI 10.1136/bmjsrh-2022-201722
  4. Pain management for medical abortion before 14 weeks' gestation.
    Reynolds-Wright JJ, Woldetsadik MA, Morroni C, Cameron S. · · 2022 · cited 7× · PMID 35553047 · DOI 10.1002/14651858.cd013525.pub2
  5. Medical abortion in Ghana: A non-randomized, non-inferiority study of access through pharmacies compared with clinics.
    Kapp N, Bawah AA, Agula C, Menzel JL, et al · · 2024 · cited 4× · PMID 39002625 · DOI 10.1016/j.contraception.2024.110538

Verify or expand the search:

Other Ipas trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03727308.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing